S-腺苷甲硫氨酸-转甲状腺素蛋白评分：非白种人群的未来如何？ - Suppr

Suppr

超能文献

SAMe-TTR Score: What Is the Future for Non-Caucasian Populations?

作者信息

Chen Yundai

机构信息

Medical School of Chinese PLA, Department of Cardiology, Chinese PLA General Hospital, Beijing, China.

出版信息

JACC Asia. 2024 Nov 26;5(1):214-217. doi: 10.1016/j.jacasi.2024.09.011. eCollection 2025 Jan.

DOI:10.1016/j.jacasi.2024.09.011

PMID:39896249

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11782095/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed07/11782095/2200329efe05/ga1.jpg

相似文献

SAMe-TTR Score: What Is the Future for Non-Caucasian Populations?S-腺苷甲硫氨酸-转甲状腺素蛋白评分：非白种人群的未来如何？

JACC Asia. 2024 Nov 26;5(1):214-217. doi: 10.1016/j.jacasi.2024.09.011. eCollection 2025 Jan.

The Sex, Age, Medical History, Treatment, Tobacco Use, Race Risk (SAMe TTR) Score Predicts Warfarin Control in a Singaporean Population.性别、年龄、病史、治疗、烟草使用、种族风险（SAMe TTR）评分可预测新加坡人群对华法林的控制情况。

J Stroke Cerebrovasc Dis. 2017 Jan;26(1):64-69. doi: 10.1016/j.jstrokecerebrovasdis.2016.08.030. Epub 2016 Sep 23.

Efficacy and safety outcomes of patients with atrial fibrillation compared between warfarin and non-vitamin K antagonist oral anticoagulants based on SAMe-TTR score.基于 SAMe-TTR 评分的华法林与非维生素 K 拮抗剂口服抗凝剂比较房颤患者的疗效和安全性结局。

BMC Cardiovasc Disord. 2023 Jan 23;23(1):43. doi: 10.1186/s12872-023-03053-w.

Use of SAMe-TTR in a racially diverse anticoagulation clinic: prediction of optimal anticoagulation.在一个种族多样化的抗凝治疗诊所中使用 SAMe-TTR：预测最佳抗凝效果。

J Thromb Thrombolysis. 2023 Jan;55(1):175-180. doi: 10.1007/s11239-022-02722-5. Epub 2022 Nov 9.

CHA2DS2-VASc and SAMe-TT2R2 scores as predictors of recurrence for nonvalvular atrial fibrillation patients on vitamin K antagonists after radiofrequency catheter ablation.CHA2DS2-VASc 和 SAMe-TT2R2 评分作为华法林抗凝治疗后射频消融的非瓣膜性心房颤动患者复发的预测因子。

J Cardiovasc Med (Hagerstown). 2020 Mar;21(3):200-208. doi: 10.2459/JCM.0000000000000930.

Use of the SAMe-TT2R2 Score to Predict Good Anticoagulation Control with Warfarin in Chinese Patients with Atrial Fibrillation: Relationship to Ischemic Stroke Incidence.使用SAMe-TT2R2评分预测中国房颤患者华法林抗凝治疗的良好控制情况：与缺血性卒中发生率的关系

PLoS One. 2016 Mar 24;11(3):e0150674. doi: 10.1371/journal.pone.0150674. eCollection 2016.

Modified application of SAMe-TT2R2 scoring system in Asian patients with atrial fibrillation for the selection of oral anticoagulants.SAMe-TT2R2 评分系统在亚洲房颤患者中选择口服抗凝剂的改良应用。

Korean J Intern Med. 2024 May;39(3):458-468. doi: 10.3904/kjim.2023.381. Epub 2024 Jan 30.

Impact of Educational Intervention on Anticoagulation Control Using SAMe-TT2R Score-Guided Strategy in Atrial Fibrillation.教育干预对采用SAMe-TT2R评分指导策略的房颤抗凝控制的影响

JACC Asia. 2024 Oct 8;5(1):205-213. doi: 10.1016/j.jacasi.2024.08.011. eCollection 2025 Jan.

Relation of the SAMe-TT2R2 score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: Observations from the SPORTIF trials.SAME-TT2R2评分与心房颤动患者抗凝控制质量及血栓栓塞事件的关系：来自SPORTIF试验的观察结果

Int J Cardiol. 2016 Aug 1;216:168-72. doi: 10.1016/j.ijcard.2016.04.131. Epub 2016 Apr 19.

SAMe-TT2R2 score for prediction of suboptimal time in therapeutic range in a Thai population with atrial fibrillation.SAMe-TT2R2 评分预测泰国心房颤动患者治疗范围内时间不足。

Singapore Med J. 2020 Dec;61(12):641-646. doi: 10.11622/smedj.2019143. Epub 2019 Nov 4.

本文引用的文献

Warfarin-A natural anticoagulant: A review of research trends for precision medication.华法林-一种天然抗凝剂：精准药物研究趋势综述。

Phytomedicine. 2024 Jun;128:155479. doi: 10.1016/j.phymed.2024.155479. Epub 2024 Feb 23.

Oral Anticoagulants Beyond Warfarin.口服抗凝药物：华法林以外的选择

Annu Rev Pharmacol Toxicol. 2024 Jan 23;64:551-575. doi: 10.1146/annurev-pharmtox-032823-122811. Epub 2023 Sep 27.

SAMe-TTR to Predict Clinical Outcomes and Time in Therapeutic Range in Patients on Vitamin K Antagonists: A Systematic Review and Meta-Analysis.同型半胱氨酸-转甲状腺素蛋白预测维生素K拮抗剂治疗患者的临床结局和治疗范围内的时间：一项系统评价和荟萃分析

Ann Pharmacother. 2024 Feb;58(2):126-139. doi: 10.1177/10600280231166643. Epub 2023 Apr 26.

Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation.移动医疗技术改善房颤患者的护理。

J Am Coll Cardiol. 2020 Apr 7;75(13):1523-1534. doi: 10.1016/j.jacc.2020.01.052.

SAMe-TT2R2 score for prediction of suboptimal time in therapeutic range in a Thai population with atrial fibrillation.SAMe-TT2R2 评分预测泰国心房颤动患者治疗范围内时间不足。

Singapore Med J. 2020 Dec;61(12):641-646. doi: 10.11622/smedj.2019143. Epub 2019 Nov 4.

Optimizing primary care management of atrial fibrillation: The rationale and methods of the Integrated Management Program Advancing Community Treatment of Atrial Fibrillation (IMPACT-AF) study.优化心房颤动的初级保健管理：推进心房颤动社区治疗综合管理计划（IMPACT-AF）研究的基本原理和方法。

Am Heart J. 2018 Jul;201:149-157. doi: 10.1016/j.ahj.2018.04.008. Epub 2018 Apr 7.

Integrating genotypes in the SAMe-TTR score for the prediction of anticoagulation control in Chinese patients with atrial fibrillation on warfarin.将基因型纳入SAME-TTR评分以预测中国华法林治疗房颤患者的抗凝控制情况。

Int J Cardiol. 2017 Aug 15;241:358-363. doi: 10.1016/j.ijcard.2017.04.092. Epub 2017 Apr 29.

Predictors of anticoagulation quality in 15 834 patients performing patient self-management of oral anticoagulation with vitamin K antagonists in real-life practice: a survey of the International Self-Monitoring Association of Orally Anticoagulated Patients.在现实生活中，15834例使用维生素K拮抗剂进行口服抗凝自我管理的患者抗凝质量的预测因素：口服抗凝患者国际自我监测协会的一项调查

Br J Haematol. 2016 Nov;175(4):677-685. doi: 10.1111/bjh.14273. Epub 2016 Jul 29.

PLoS One. 2016 Mar 24;11(3):e0150674. doi: 10.1371/journal.pone.0150674. eCollection 2016.

The SAMe-TT2R2 score and decision-making between a vitamin K antagonist or a non-vitamin K antagonist oral anticoagulant in patients with atrial fibrillation.SAMe-TT2R2评分与心房颤动患者维生素K拮抗剂或非维生素K拮抗剂口服抗凝剂之间的决策

Expert Rev Cardiovasc Ther. 2016;14(2):177-87. doi: 10.1586/14779072.2016.1116941. Epub 2015 Dec 9.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验